A Combination of Tachycardia-Mediated Heart Failure and Coronary Artery Vasospasm-Induced Silent Myocardial Infarction in a Patient with Severe Thyrotoxicosis
Severe thyrotoxicosis can present with a myriad of cardiovascular complications. It may be mild features such as palpitations, tachycardia, and exertional dyspnea or may progress to life-threatening consequences such as atrial fibrillation, tachyarrhythmias, heart failure, myocardial infarction, and...
Saved in:
Main Authors: | Serena Sert Kim Khoo, Chong Mow Chu, Yin Khet Fung |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2018/4827907 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macrophage Activities in Myocardial Infarction and Heart Failure
by: Sophia Esi Duncan, et al.
Published: (2020-01-01) -
Rituximab-Induced Coronary Vasospasm
by: Linda Lee, et al.
Published: (2012-01-01) -
Thyrotoxicosis due to Gestational Trophoblastic Disease: Unmet Needs in the Management of Gestational Thyrotoxicosis
by: Kalyan Mansukhbhai Shekhda, et al.
Published: (2024-01-01) -
Postpartum Coronary Vasospasm with Literature Review
by: Jayanth Koneru, et al.
Published: (2014-01-01) -
Plasma biomarkers for predicting heart failure in patients with acute myocardial infarction
by: Guihong Rong, et al.
Published: (2025-01-01)